Conclusions
SECONDARY
In this secondary analysis of a large randomized, multicenter phase 3 clinical trial, we showed using high-quality patient-level data that Black patients had similar survival outcomes to White patients with mCSPC. These results support the hypothesis that equitable access to care as available in a clinical trial setting negates disparities in outcomes previously associated with Black patient populations. Possible avenues for action include accounting for variables linked to SDOH in research and tackling modifiable cultural, economic, and geographic factors in clinical settings.